-
1
SHED cells are derived from exfoliated baby teeth.
-
2
The therapy aims to treat pediatric cerebral palsy.
-
3
It is noninvasive and cells can be expanded in culture.
-
4
Treatment showed improvements in some motor functions.
-
5
Generally well tolerated with no reported serious adverse events.
-
6
Needs further research for long-term safety and efficacy.
-
7
SHED cells possess neurotrophic and immunomodulatory properties.
-
8
Clinical trials required for conclusive evidence.
Original Source(s)
Related Content
St. Louis Pediatrician Gets 20-Year Sentence
A physician exploited patients with addiction for nearly a decade, trading prescriptions for sex acts, photos, and cash
by Kerri Miller
March 26, 2026
-
3 min
Youth Self-Injury Visits Rise Annually
A meta-analysis in 12 high-income countries found increasing health care encounters for self-injury among patients aged 24 years and younger, with steeper rises among female patients.
by Kerri Miller
March 19, 2026
-
4 min
Multiple Magnet Ingestion
Case report highlights need for increased clinician awareness when reviewing pediatric cases presenting with prolonged abdominal pain
March 19, 2026
-
3 min
